Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
5 "L cells"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Lymphoma
Forkhead Box C1 (FOXC1) Expression in Stromal Cells within the Microenvironment of T and NK Cell Lymphomas: Association with Tumor Dormancy and Activation
Ji Hae Nahm, Woo Ick Yang, Sun Och Yoon
Cancer Res Treat. 2020;52(4):1273-1282.   Published online July 3, 2020
DOI: https://doi.org/10.4143/crt.2020.032
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Forkhead box C1 (FOXC1) is critical for maintaining bone marrow microenvironments during hematopoiesis, but its role in hematological malignancies remains obscure. Here, we investigated whether FOXC1 regulates tumor dormancy and activation in the microenvironments of T and natural killer (NK) cell lymphomas.
Materials and Methods
One hundred and twenty cases of T and NK cell lymphomas were included; the immunohistochemical expression of FOXC1 was investigated in stromal cells, and numbers of FOXC1+ stromal cells were counted. Furthermore, the expression of phosphorylated p38 (p-p38) and phosphorylated ERK1/2 (p-ERK1/2) in tumor cells was investigated using immunohistochemistry.
Results
FOXC1 was variably expressed in C-X-C motif chemokine 12–associated reticular stromal cells, histiocytes, (myo)fibroblasts, and endothelial cells. The phenotypes of cases were categorized as dormant (high p-p38/low p-ERK1/2; n=30, 25.0%), active (high p-ERK1/2/low p-p38; n=25, 20.8%), or intermediate (others; n=65, 54.2%). Lower FOXC1+ stromal cell infiltration was associated with the dormant phenotype, the precursor T lymphoblastic leukemia/lymphoma subtype, and inferior overall survival rates, whereas higher FOXC1+ stromal cell infiltration was associated with the active phenotype and favorable patient prognosis (p < 0.05 for all).
Conclusion
These results suggested that FOXC1+ stromal cells within the microenvironments of T and NK cell lymphomas might be related to tumor phenotypes.

Citations

Citations to this article as recorded by  
  • Mechanisms of lymphoma-stromal interactions focusing on tumor-associated macrophages, fibroblastic reticular cells, and follicular dendritic cells
    Rintaro Ohe
    Journal of Clinical and Experimental Hematopathology.2024; 64(3): 166.     CrossRef
  • 8,761 View
  • 113 Download
  • 5 Web of Science
  • 1 Crossref
Close layer
Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
Boyun Kim, Hee Seung Kim, Soochi Kim, Guy Haegeman, Benjamin K. Tsang, Danny N. Dhanasekaran, Yong Sang Song
Cancer Res Treat. 2017;49(2):338-349.   Published online July 18, 2016
DOI: https://doi.org/10.4143/crt.2016.175
AbstractAbstract PDFPubReaderePub
Purpose
Adipose stromal cells (ASCs) play an important regulatory role in cancer progression and metastasis by regulating systemic inflammation and tissue metabolism. This study examined whether visceral and subcutaneous ASCs (V- and S-ASCs) facilitate the growth and migration of ovarian cancer cells.
Materials and Methods
CD45– and CD31– double-negative ASCs were isolated from the subcutaneous and visceral fat using magnetic-activated cell sorting. Ovarian cancer cells were cultured in conditioned media (CM) obtained from ASCs to determine the cancer-promoting effects of ASCs. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, Boyden chamber assay, and western blotting were performed to determine the proliferative activity, migration ability, and activation of the JAK2/STAT3 pathway, respectively.
Results
CM from ASCs enhanced the migration of the ovarian cancer line, SKOV3, via activation of the JAK2/STAT3 signaling pathway. Interestingly, in response to ASC-CM, the ascites cells derived from an ovarian cancer patient showed an increase in growth and migration. The migration of ovarian cancer cells was suppressed by blocking the activation of JAK2 and STAT3 using a neutralizing antibody against interleukin 6, small molecular inhibitors (e.g., WP1066 and TG101348), and silencing of STAT3 using siRNA. Anatomical differences between S- and V-ASCs did not affect the growth and migration of the ovarian cancer cell line and ascites cells from the ovarian cancer patients.
Conclusion
ASCs may regulate the progression of ovarian cancer, and possibly provide a potential target for anticancer therapy.

Citations

Citations to this article as recorded by  
  • Quercetin-3-Glucoside from Ocimum basilicum ameliorates polycystic ovary syndrome by targeting the IL-6/JAK-STAT3 signaling axis
    Hina Majid Khan, Imran Tarique, Mohadsa Zainab, Syeda Maryam Hussain, Nimra Rehman
    Journal of Reproductive Immunology.2026; 175: 104905.     CrossRef
  • Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study
    Yanxin Chen, Yuxi Luo, Yunwei Liu, Daya Luo, Anwen Liu
    Cancer Immunology, Immunotherapy.2025;[Epub]     CrossRef
  • The Role of Perirenal Adipose Tissue in Carcinogenesis—From Molecular Mechanism to Therapeutic Perspectives
    Adriana Grigoraș, Cornelia Amalinei
    Cancers.2025; 17(7): 1077.     CrossRef
  • Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements
    Yang Wang, Na Zhu, Jing Liu, Fang Chen, Yang Song, Yue Ma, Zhuo Yang, Danbo Wang
    Journal of Translational Medicine.2025;[Epub]     CrossRef
  • Design, synthesis and SAR of novel naphthalene–sulfonamide hybrids: anticancer assessment, gene expression analysis of IL6/JAK2/STAT3 signaling in MCF7 cells and antimicrobial evaluation
    Ghada H. Elsayed, Nagwa M. Abdelazeem, Alaa M. Saleh, Sherein Abd El-Moez, Marwa El-Hussieny, Aisha A. K. Al-Ashmawy
    RSC Advances.2025; 15(44): 37391.     CrossRef
  • Multi-omics study of prognostic models and molecular networks related to ovarian cancer
    Piaopiao Bian, Shaoyan Liu, Wei Zhang, Qiuping Luo, Zhongtang Xiong
    Discover Oncology.2025;[Epub]     CrossRef
  • Association Between Adipose Tissue Distribution and Survival in Recurrent Ovarian Cancer Patients Treated With Anti‐VEGF Therapy: A Retrospective CT‐Based Analysis
    Simay Cokgezer, Muhammet Senkal, Aysel Safaraliyeva, Helin Kose, İnci Kizildag Yırgın, Pınar Mualla Saıp, Naziye Ak
    Journal of Obstetrics and Gynaecology Research.2025;[Epub]     CrossRef
  • WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin
    Jun Yang, Nanjing Li, Xinyu Zhao, Wenhao Guo, Yang Wu, Chunlai Nie, Zhu Yuan
    Biochemical Pharmacology.2024; 221: 116040.     CrossRef
  • Impact of Obesity and Lysosomal Dysfunction on Chemoresistance in Ovarian Cancer
    Boyun Kim, Jewon Jung
    Biomedicines.2024; 12(3): 604.     CrossRef
  • SYT7 as a Potential Prognostic Marker Promotes the Metastasis of Epithelial Ovarian Cancer Cells by Activating the STAT3 Pathway
    Yinguang Li, Fengping Shao, Ying Huang, Qian Yin, Jun Liu, Yunhe Zhao, Linjing Yuan
    Molecular Carcinogenesis.2024; 63(12): 2441.     CrossRef
  • Expression of LncRNAs in anterior capsule of lens in patients with pathologic myopia complicated with cataract
    Yaru Hu, Yuchen Fan, Na Li, Che Xu, Jianfeng Wang
    International Ophthalmology.2024;[Epub]     CrossRef
  • Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
    Magdalena Bizoń, Zofia Awiżeń-Panufnik, Włodzimierz Sawicki
    Journal of Personalized Medicine.2023; 13(6): 980.     CrossRef
  • The potential role of interleukins and interferons in ovarian cancer
    Huldani Huldani, Sana Abdul-Jabbar Ali, F. Al-dolaimy, Ahmed Hjazi, Nikolenko Denis Andreevich, Khulood H. Oudaha, Abbas F. Almulla, Ali Alsaalamy, Shamam Kareem Oudah, Yasser Fakri Mustafa
    Cytokine.2023; 171: 156379.     CrossRef
  • ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling
    Yabing Hu, Yongchu Huang, Xiaohang Xie, Longshan Li, Yong Zhang, Xiaochao Zhang
    Cancer Cell International.2023;[Epub]     CrossRef
  • M1 Macrophages Enhance Survival and Invasion of Oral Squamous Cell Carcinoma by Inducing GDF15-Mediated ErbB2 Phosphorylation
    Chunxu Lv, Shutong Li, Jingjing Zhao, Pishan Yang, Chengzhe Yang
    ACS Omega.2022; 7(13): 11405.     CrossRef
  • Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
    Hussein Chehade, Roslyn Tedja, Harry Ramos, Tejeshwar Singh Bawa, Nicholas Adzibolosu, Radhika Gogoi, Gil Mor, Ayesha B. Alvero
    Cancers.2022; 14(9): 2267.     CrossRef
  • The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer
    Bruce A. Bunnell, Elizabeth C. Martin, Margarite D. Matossian, Courtney K. Brock, Khoa Nguyen, Bridgette Collins-Burow, Matthew E. Burow
    Cancer and Metastasis Reviews.2022; 41(3): 549.     CrossRef
  • The role of IL-6/JAK2/STAT3 signaling pathway in cancers
    Bei Huang, Xiaoling Lang, Xihong Li
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Adaptation of metabolism to multicellular aggregation, hypoxia and obese stromal cell incorporation as potential measure of survival of ovarian metastases
    Stephanie L.E. Compton, Emily S. Pyne, Lu Liu, Jack Guinan, Amanda A. Shea, Joseph P. Grieco, Madlyn I. Frisard, Eva M. Schmelz
    Experimental Cell Research.2021; 399(1): 112397.     CrossRef
  • Perirenal Adipose Tissue—Current Knowledge and Future Opportunities
    Adriana Grigoraș, Raluca Anca Balan, Irina-Draga Căruntu, Simona Eliza Giușcă, Ludmila Lozneanu, Roxana Elena Avadanei, Andreea Rusu, Laura Adriana Riscanu, Cornelia Amalinei
    Journal of Clinical Medicine.2021; 10(6): 1291.     CrossRef
  • Mesenchymal Stem Cells in Adipose Tissue and Extracellular Vesicles in Ovarian Cancer Patients: A Bridge toward Metastatic Diffusion or a New Therapeutic Opportunity?
    Gabriele Storti, Maria Giovanna Scioli, Bong-Sung Kim, Sonia Terriaca, Elena Fiorelli, Augusto Orlandi, Valerio Cervelli
    Cells.2021; 10(8): 2117.     CrossRef
  • Obesity Promotes Tumor Immune Evasion in Ovarian Cancer Through Increased Production of Myeloid-Derived Suppressor Cells via IL-6
    Qiannan Yang, Bojun Yu, Jiuhong Kang, Ang Li, Jing Sun
    Cancer Management and Research.2021; Volume 13: 7355.     CrossRef
  • Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer
    Qingling Han, Se Ik Kim, Soon Ho Yoon, Taek Min Kim, Hyun-Cheol Kang, Hak Jae Kim, Jeong Yeon Cho, Jae-Weon Kim
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
    Izabela Szulc-Kielbik, Michal Kielbik, Marek Nowak, Magdalena Klink
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1876(2): 188639.     CrossRef
  • A Role for Adipocytes and Adipose Stem Cells in the Breast Tumor Microenvironment and Regenerative Medicine
    Courtney K. Brock, Katherine L. Hebert, Maria Artiles, Maryl K. Wright, Thomas Cheng, Gabrielle O. Windsor, Khoa Nguyen, Madlin S. Alzoubi, Bridgette M. Collins-Burow, Elizabeth C. Martin, Frank H. Lau, Bruce A. Bunnell, Matthew E. Burow
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Dietary fats promote inflammation in Wistar rats as well as induce proliferation, invasion of SKOV3 ovarian cancer cells
    Jafar Saeidi, Reza Motaghipur, Atefe Sepehrian, Mahnaz Mohtashami, Fatemeh Forooghi Nia, Ahmad Ghasemi
    Journal of Food Biochemistry.2020;[Epub]     CrossRef
  • Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
    Se Ik Kim, Taek Min Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jeong Yeon Cho, Yong Sang Song
    Cancers.2020; 12(3): 559.     CrossRef
  • Stomatin-like Protein 2 Promotes Tumor Cell Survival by Activating the JAK2-STAT3-PIM1 Pathway, Suggesting a Novel Therapy in CRC
    Qiang Liu, Anqi Li, Lisha Wang, Wei He, Ling Zhao, Chao Wu, Shasha Lu, Xuanguang Ye, Huiyong Zhao, Xiaohan Shen, Xiuying Xiao, Zebing Liu
    Molecular Therapy - Oncolytics.2020; 17: 169.     CrossRef
  • Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics
    Syeda Samira Afrose, Md. Junaid, Yeasmin Akter, Mousumi Tania, Meiling Zheng, Md. Asaduzzaman Khan
    Drug Discovery Today.2020; 25(12): 2294.     CrossRef
  • Sarcopenia: Clinical implications in ovarian cancer, diagnosis, etiology, and management
    Aeran Seol, Se Ik Kim, Yong Sang Song
    Sports Medicine and Health Science.2020; 2(4): 202.     CrossRef
  • Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
    Karen McLean, Lijun Tan, Danielle E. Bolland, Lan G. Coffman, Luke F. Peterson, Moshe Talpaz, Nouri Neamati, Ronald J. Buckanovich
    Oncogene.2019; 38(9): 1576.     CrossRef
  • Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer
    Youngjin Han, HyunA Jo, Jae Hyun Cho, Danny N. Dhanasekaran, Yong Sang Song
    International Journal of Molecular Sciences.2019; 20(4): 925.     CrossRef
  • Adipose Stem Cells and Cancer: Concise Review
    Rachel A. Sabol, Paulina Giacomelli, Adam Beighley, Bruce A. Bunnell
    Stem Cells.2019; 37(10): 1261.     CrossRef
  • Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
    Youngjin Han, Boyun Kim, Untack Cho, In Sil Park, Se Ik Kim, Danny N. Dhanasekaran, Benjamin K. Tsang, Yong Sang Song
    Oncogene.2019; 38(45): 7089.     CrossRef
  • Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity
    Chin-Jui Wu, Vignesh Sundararajan, Bor-Ching Sheu, Ruby Yun-Ju Huang, Lin-Hung Wei
    Cancers.2019; 12(1): 24.     CrossRef
  • Pro‐inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF‐κB activation
    Untack Cho, Boyun Kim, Soochi Kim, Youngjin Han, Yong Sang Song
    Molecular Carcinogenesis.2018; 57(2): 235.     CrossRef
  • Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway
    Xue Hu, Jingjing Ma, Vikash Vikash, Jiao Li, Dandan Wu, Ya Liu, Jixiang Zhang, Weiguo Dong
    Digestive Diseases and Sciences.2018; 63(1): 126.     CrossRef
  • Perirenal Adiposity is Associated with Lower Progression-Free Survival from Ovarian Cancer
    Yan Zhang, Adriana M. Coletta, Pamela K. Allen, Aaroh M. Parikh, Matthes Cox-Mattin, Larissa A. Meyer, Charlotte C. Sun, Karen M. Basen-Engquist, Karen H. Lu, Ann H. Klopp
    International Journal of Gynecological Cancer.2018; 28(2): 285.     CrossRef
  • Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
    Sanhong Li, Jilai Tian, Hongming Zhang, Shoubing Zhou, Xiyong Wang, Lei Zhang, Jiapeng Yang, Zhigang Zhang, Zhenling Ji
    Apoptosis.2018; 23(5-6): 356.     CrossRef
  • Role of the body mass index in the genesis of ascites in ovarian cancer: a forensic case and review of the literature
    Isabella Aquila, Pietrantonio Ricci, Alessandra Oliverio, Santo Gratteri
    BMJ Case Reports.2018; 11(1): e226491.     CrossRef
  • The mechanism of alopolysaccharide protecting ulceralive colitis
    Hu Lin, Li Honglang, Li Weifeng, Chen Junmin, Yang Jiantao, Gu Junjing
    Biomedicine & Pharmacotherapy.2017; 88: 145.     CrossRef
  • CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression
    Ming-Horng Tsai, Chiang-Wen Lee, Lee-Fen Hsu, Shu-Yu Li, Yao-Chang Chiang, Ming-Hsueh Lee, Chun-Han Chen, Hwey-Fang Liang, Jia-Mei How, Pey-Jium Chang, Ching-Mei Wu, I-Ta Lee
    Redox Biology.2017; 12: 377.     CrossRef
  • Gene expression profiles of human subcutaneous and visceral adipose‐derived stem cells
    Boyun Kim, Boram Lee, Mi‐Kyung Kim, Seung Pyo Gong, Noh Hyun Park, Hyun Hoon Chung, Hee Seung Kim, Jae Hong No, Woong Yang Park, Ae Kyung Park, Jeong Mook Lim, Yong Sang Song
    Cell Biochemistry and Function.2016; 34(8): 563.     CrossRef
  • 17,143 View
  • 391 Download
  • 48 Web of Science
  • 43 Crossref
Close layer
The Expression of Carbonic Anhydrase (CA) IX/XII and Lymph Node Metastasis in Early Breast Cancer
Keun-Yong Eom, Min Hye Jang, So Yeon Park, Eun Young Kang, Sung Won Kim, Jee Hyun Kim, Jae-Sung Kim, In Ah Kim
Cancer Res Treat. 2016;48(1):125-132.   Published online March 3, 2015
DOI: https://doi.org/10.4143/crt.2014.243
AbstractAbstract PDFPubReaderePub
Purpose
The aim of study was to test by immunohistochemical (IHC) staining whether carbonic anhydrase (CA) 9 and 12 have an effect on sentinel lymph node (SLN) metastasis in early breast cancer and to find clinicopathologic factors associated with SLN metastasis.
Materials and Methods
Between June 2003 and June 2011, medical records of 470 patients diagnosedwith breast cancer with pT1-2, pN0-2, and M0 were reviewed. Of these 470, 314 patients who underwent SLN biopsy±axillary dissection were subjects of this study. Using tissue microarray, IHC staining for CA9 and CA12 was performed. Clinicopathologic factors such as patient age, tumour size, lymphatic invasion, hormone receptor status, and the Ki-67 labeling index were analysed together.
Results
The mean age of all patients was 51.7 years. The mean number of harvested SLN was 3.62, and 212 patients (67.5%) had negative SLN. Lymphatic invasion, the Ki-67 labelling index of primary tumours, and CA9 staining of stromal cells, were independent risk factors for SLN metastasis in the multivariate analysis. In 33 patients (10.5%) without the three risk factors, no patient had SLN metastasis. In 80 patients without lymphatic invasion of primary tumours or CA9 staining of stromal cells, only four patients (5%) had positive SLN.
Conclusion
CA9 staining of stromal cells is an independent risk factor for SLN metastasis as well as lymphatic invasion and a low Ki-67 labelling index of primary tumours in patients with early breast cancer. IHC staining of primary tumours for CA12was not associatedwith SLN metastasis.

Citations

Citations to this article as recorded by  
  • The Diagnostic Role of TFF1, TFF3, FOXA1, CA XII and TRPS1 in Serous Effusions
    Ben Davidson, Arild Holth, Jeremias Wohlschlaeger, Maurizio Pinamonti, Binnur Önal
    Cytopathology.2025; 36(4): 408.     CrossRef
  • Impact of CA9 expression in the diagnosis of lymph-node metastases in non-small cell lung cancer based on [18F]FDG PET/CT
    Satoshi Suzuki, Masakazu Yashiro, Nobuhiro Izumi, Takuma Tsukioka, Hidetoshi Inoue, Kantaro Hara, Ryuichi Ito, Takuya Tanimura, Noritoshi Nishiyama, Domenico Albano
    PLOS ONE.2024; 19(10): e0312846.     CrossRef
  • Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling
    Daniele Vergara, Sara Ravaioli, Eugenio Fonzi, Loredaria Adamo, Marina Damato, Sara Bravaccini, Francesca Pirini, Antonio Gaballo, Raffaela Barbano, Barbara Pasculli, Julien Franck, Isabelle Fournier, Michel Salzet, Michele Maffia
    International Journal of Molecular Sciences.2020; 21(3): 715.     CrossRef
  • The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer
    Khalid O. Alfarouk, Samrein B. M. Ahmed, Ahmed Ahmed, Robert L. Elliott, Muntaser E. Ibrahim, Heyam S. Ali, Christian C. Wales, Ibrahim Nourwali, Ahmed N. Aljarbou, Adil H. H. Bashir, Sari T. S. Alhoufie, Saad Saeed Alqahtani, Rosa A. Cardone, Stefano Fai
    Cancers.2020; 12(4): 898.     CrossRef
  • Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer
    Shaoquan Zheng, Yutian Zou, Jie‐ying Liang, Weikai Xiao, Anli Yang, Tiebao Meng, Shilin Lu, Zhongbing Luo, Xiaoming Xie
    Molecular Oncology.2020; 14(11): 2814.     CrossRef
  • The roles of carbonic anhydrases IX and XII in cancer cell adhesion, migration, invasion and metastasis
    Simonas Daunys, Vilma Petrikaitė
    Biology of the Cell.2020; 112(12): 383.     CrossRef
  • Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
    Min-Sun Jin, Hyebin Lee, In Ae Park, Yul Ri Chung, Seock-Ah Im, Kyung-Hun Lee, Hyeong-Gon Moon, Wonshik Han, Kyubo Kim, Tae-Yong Kim, Dong-Young Noh, Han Suk Ryu
    Virchows Archiv.2016; 469(2): 183.     CrossRef
  • Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker
    Bo Lei, Xian-yu Zhang, Jia-peng Zhou, Guan-nan Mu, Yi-wen Li, You-xue Zhang, Da Pang
    Tumor Biology.2016; 37(11): 14757.     CrossRef
  • Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression
    Manjulata Singh, Shilpaa Mukundan, Maria Jaramillo, Steffi Oesterreich, Shilpa Sant
    Cancer Research.2016; 76(13): 3732.     CrossRef
  • 16,591 View
  • 127 Download
  • 11 Web of Science
  • 9 Crossref
Close layer
Prognostic Significance of Defining L-Cell Type on the Biologic Behavior of Rectal Neuroendocrine Tumors in Relation with Pathological Parameters
The Gastrointestinal Pathology Study Group of Korean Society of Pathologists, Jin Hee Sohn, Mee-Yon Cho, Yangsoon Park, Hyunki Kim, Woo Ho Kim, Joon Mee Kim, Eun Sun Jung, Kyoung-Mee Kim, Jae Hyuk Lee, Hee Kyung Chan, Do Youn Park, Mee Joo, Sujin Kim, Woo Sung Moon, Mi Seon Kang, So-Young Jin, Yun Kyung Kang, Sun Och Yoon, HyeSeung Han, EunHee Choi
Cancer Res Treat. 2015;47(4):813-822.   Published online February 26, 2015
DOI: https://doi.org/10.4143/crt.2014.238
AbstractAbstract PDFPubReaderePub
Purpose
In 2010, the World Health Organization categorized L-cell type neuroendocrine tumors (NETs) as tumors of uncertain malignancy, while all others were classified as malignant. However, the diagnostic necessity of L-cell immunophenotyping is unclear, as are tumor stage and grade that may guide diagnosis and management. To clarify the predictive markers of rectal neuroendocrine neoplasms (NENs), 5- and 10-year overall survival (OS) was analyzed by pathological parameters including L-cell phenotype. Materials and Methods A total of 2,385 rectal NENs were analyzed from our previous multicenter study and a subset of 170 rectal NENs was immunophenotyped.
Results
In univariate survival analysis, tumor grade (p < 0.0001), extent (p < 0.0001), size (p < 0.0001), lymph node metastasis (p=0.0063), and L-cell phenotype (p < 0.0001) showed significant correlation with the prognosis of rectal NENs; however, none of these markers achieved independent significance in multivariate analysis. The 10-year OS of tumors of NET grade 1, < 10 mm, the mucosa/submucosa was 97.58%, 99.47%, and 99.03%, respectively. L-Cell marker, glucagon II (GLP-1&2), with a cut off score of > 10, is useful in defining L-Cell type. In this study, an L-cell immunophenotype was found in 83.5% of all rectal NENs and most, but not all L-cell type tumors were NET G1, small (< 10 mm) and confined to the mucosa/submucosa. Conclusion From these results, the biological behavior of rectal NENs does not appear to be determined by L-cell type alone but instead by a combination of pathological parameters.

Citations

Citations to this article as recorded by  
  • Comprehensive next generation sequencing of middle ear neuroendocrine tumors
    Justin A. Bishop, Jing Xu, Lester D.R. Thompson
    Annals of Diagnostic Pathology.2026; 82: 152620.     CrossRef
  • Well-Differentiated Neuroendocrine Tumors of Lung: A Case Series Supporting the IARC/WHO Common Classification of Neuroendocrine Tumor Nomenclature and Grading
    Eren Altun, Omid Savari, Mart Andrew Maravillas, Sylvia L. Asa
    Endocrine Pathology.2026;[Epub]     CrossRef
  • Is There a Relationship between the Staining Pattern of Classical Neuroendocrine Markers and Clinicopathological Findings in Neuroendocrine Tumors of the Appendix?
    Merve CİN, Enver YARIKKAYA, Selçuk CİN, Özgecan GÜNDOĞAR
    Bezmialem Science.2025; 13(1): 65.     CrossRef
  • Extended Hormone Profiling Identifies a Wider Network of Duodenal Neuroendocrine Tumor Subtypes
    Luvy Delfin, Shereen Ezzat, Sylvia L. Asa
    Endocrine Pathology.2025;[Epub]     CrossRef
  • Endoscopic Resection of Rectal Neuroendocrine Tumors: Pathologic Risk Stratification and Surveillance Strategies
    Ji Eun Kim
    Journal of Digestive Cancer Research.2025; 13(3): 228.     CrossRef
  • Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
    Joo Young Kim, Jisup Kim, Yong-il Kim, Dong-Hoon Yang, Changhoon Yoo, In Ja Park, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    Scientific Reports.2024;[Epub]     CrossRef
  • The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors
    Ozgur Mete, David W. Dodington, Daniel L. Shen, Sylvia L. Asa
    Endocrine Pathology.2024; 35(2): 107.     CrossRef
  • Cauda Equina Neuroendocrine Tumors
    Sylvia L. Asa, Ozgur Mete, Ulrich Schüller, Biswarathan Ramani, Kanish Mirchia, Arie Perry
    American Journal of Surgical Pathology.2023; 47(4): 469.     CrossRef
  • Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future
    Stefano La Rosa
    Endocrine Pathology.2023; 34(1): 79.     CrossRef
  • Clinicopathologic Impact of Peptide Hormonal Expression in Rectal Neuroendocrine Tumors
    Jisup Kim, Dong-Hoon Yang, HaeSung Jung, HyungJun Cho, Hyeung-Jin Jang, Changhoon Yoo, In Ja Park, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2023; 147(7): 797.     CrossRef
  • Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?
    Jack Cope, Raj Srirajaskanthan
    Current Oncology Reports.2022; 24(3): 257.     CrossRef
  • Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms
    Guido Rindi, Ozgur Mete, Silvia Uccella, Olca Basturk, Stefano La Rosa, Lodewijk A. A. Brosens, Shereen Ezzat, Wouter W. de Herder, David S. Klimstra, Mauro Papotti, Sylvia L. Asa
    Endocrine Pathology.2022; 33(1): 115.     CrossRef
  • Rectal neuroendocrine neoplasms: what the radiologists should know
    Mayur Virarkar, Dheeraj R. Gopireddy, Ajaykumar C. Morani, Ahmad Alkhasawneh, Sergio Piotr Klimkowski, Sindhu Kumar, Chandana Lall, Priya Bhosale
    Abdominal Radiology.2022; 47(12): 4016.     CrossRef
  • Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
    Amr Mohamed, Sulin Wu, Mohamed Hamid, Amit Mahipal, Sakti Cjakrabarti, David Bajor, J. Eva Selfridge, Sylvia L. Asa
    Cancers.2022; 15(1): 295.     CrossRef
  • Composite intestinal adenoma-microcarcinoid: An update and literature review
    Zhi-Yan Fu, Michel Kmeid, Mahmoud Aldyab, Stephen M Lagana, Hwajeong Lee
    World Journal of Gastrointestinal Endoscopy.2021; 13(12): 593.     CrossRef
  • Classification of neuroendocrine neoplasms: lights and shadows
    Stefano La Rosa, Silvia Uccella
    Reviews in Endocrine and Metabolic Disorders.2021; 22(3): 527.     CrossRef
  • Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
    Sylvia L. Asa, Ozgur Mete, Michael D. Cusimano, Ian E. McCutcheon, Arie Perry, Shozo Yamada, Hiroshi Nishioka, Olivera Casar-Borota, Silvia Uccella, Stefano La Rosa, Ashley B. Grossman, Shereen Ezzat, International Pituitary Pathology, Sofia Asioli, Sühe
    Modern Pathology.2021; 34(9): 1634.     CrossRef
  • Middle Ear “Adenoma”: a Neuroendocrine Tumor with Predominant L Cell Differentiation
    Sylvia L. Asa, Knarik Arkun, Arthur S. Tischler, Adnan Qamar, Fang-Ming Deng, Bayardo Perez-Ordonez, Ilan Weinreb, Justin A. Bishop, Bruce M. Wenig, Ozgur Mete
    Endocrine Pathology.2021; 32(4): 433.     CrossRef
  • Chromogranin A Expression in Rectal Neuroendocrine Tumors Is Associated With More Aggressive Clinical Behavior and a Poorer Prognosis
    Jisup Kim, Joo Young Kim, Eun Hye Oh, Changhoon Yoo, In Ja Park, Dong-Hoon Yang, Baek-Yeol Ryoo, Jin-Sook Ryu, Seung-Mo Hong
    American Journal of Surgical Pathology.2020; 44(11): 1496.     CrossRef
  • Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors
    Louis de Mestier, Diane Lorenzo, Caroline Fine, Jérôme Cros, Olivia Hentic, Thomas Walter, Yves Panis, Anne Couvelard, Guillaume Cadiot, Philippe Ruszniewski
    Best Practice & Research Clinical Endocrinology & Metabolism.2019; 33(5): 101293.     CrossRef
  • Novel Finding of Paired Box 5 (PAX5) Cytoplasmic Staining in Well-differentiated Rectal Neuroendocrine Tumors (Carcinoids) and Its Diagnostic and Potentially Prognostic Utility
    Zhiyan Fu, Chunlai Zuo, Christine E. Sheehan, Deepa T. Patil, Jingmei Lin, Zhaohai Yang, Hwajeong Lee
    Applied Immunohistochemistry & Molecular Morphology.2019; 27(6): 454.     CrossRef
  • Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms
    Günter Klöppel, Stefano La Rosa
    Virchows Archiv.2018; 472(3): 341.     CrossRef
  • Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms
    Silvia Uccella, Stefano La Rosa, Marco Volante, Mauro Papotti
    Endocrine Pathology.2018; 29(2): 150.     CrossRef
  • Algorithmic approach to neuroendocrine tumors in targeted biopsies: Practical applications of immunohistochemical markers
    Kai Duan, Ozgur Mete
    Cancer Cytopathology.2016; 124(12): 871.     CrossRef
  • Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts
    Joo Young Kim, Seung-Mo Hong
    Archives of Pathology & Laboratory Medicine.2016; 140(5): 437.     CrossRef
  • 16,316 View
  • 105 Download
  • 25 Web of Science
  • 25 Crossref
Close layer
Resveratrol at High Doses Acts as an Apoptotic Inducer in Endothelial Cells
Kyungmin In, Jongbong Park, Heonyong Park
Cancer Res Treat. 2006;38(1):48-53.   Published online February 28, 2006
DOI: https://doi.org/10.4143/crt.2006.38.1.48
AbstractAbstract PDFPubReaderePub
Purposes

Resveratrol is a phenolic compound found in grapes and other food products. In order to assess the availability of resveratrol as an angio-inhibiting drug, we examined whether resveratrol plays an important role in bovine aortic endothelial cells (BAECs) for cell apoptosis and cell migration.

Methods and Materials

Endothelial cell apoptosis was observed as detected by the Hoechst staining and the caspase-3 activity. Additionally, Western blotting was performed for monitoring the activities of various cell signaling molecules.

Results

Resveratrol was shown to act as a pro-apoptotic agent. The pro-apoptotic effect of resveratrol was as great as that of etoposide, a well-known anti-cancer drug. In addition, resveratrol had an inhibitory effect on endothelial cell migration. The demonstrated efficacy of resveratrol suggests that resveratrol may be utilized as an anti-angiogenic drug. To determine the underlying mechanisms, we further investigated which signaling molecules are activated by resveratrol. Extracellular signal-regulated kinase (ERK) was activated by the treatment with resveratrol in BAECs, whereas endothelial nitric oxide synthetase (eNOS), Akt, and Jun N-terminal kinase (JNK) were inhibited. The pretreatment with PD compound, an ERK inhibitor, had no effect on the pro-apoptosis induced by resveratrol.

Conclusion

Resveratrol plays an important role in endothelial cell apoptosis, indicating that resveratrol can be utilized as a potent anti-angiogenic drug.

Citations

Citations to this article as recorded by  
  • Novel plasma-polymerized coating facilitates HeLa cell spheroid formation, exerting necroptosis via β-cyclodextrin-encapsulated resveratrol
    Sujeong Jang, Namwuk Baek, Youngsik Seo, Hyuna Lim, Donggeun Jung, Heonyong Park
    Journal of Analytical Science and Technology.2024;[Epub]     CrossRef
  • Effect of eIF2α in Neuronal Injury Induced by High Glucose and the Protective Mechanism of Resveratrol
    Lijing Zhang, Kaining Zhi, Yanfang Su, Wenpeng Peng, Xianfang Meng
    Molecular Neurobiology.2023; 60(10): 6043.     CrossRef
  • A comparison of resveratrol and other polyphenolic compounds on Notch activation and endothelial cell activity
    Bryce LaFoya, Jordan A. Munroe, Allan R. Albig, Myon-Hee Lee
    PLOS ONE.2019; 14(1): e0210607.     CrossRef
  • Resveratrol-Induced Temporal Variation in the Mechanical Properties of MCF-7 Breast Cancer Cells Investigated by Atomic Force Microscopy
    Jagoba Iturri, Andreas Weber, Alberto Moreno-Cencerrado, Maria dM Vivanco, Rafael Benítez, Stefano Leporatti, José Luis Toca-Herrera
    International Journal of Molecular Sciences.2019; 20(13): 3275.     CrossRef
  • Effect of Fermented Platycodon grandiflorum Extract on Cell Proliferation and Migration in Bovine Aortic Endothelial Cells
    Woosoung Choi, Jina Song, Mi-Hyeon Park, Heui Jong Yu, Heonyong Park
    Journal of Life Science.2016; 26(1): 59.     CrossRef
  • Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells
    RUBICELI MEDINA-AGUILAR, LAURENCE A. MARCHAT, ELENA ARECHAGA OCAMPO, PATRICIO GARIGLIO, JAIME GARCÍA MENA, NICOLÁS VILLEGAS SEPÚLVEDA, MACARIO MARTÍNEZ CASTILLO, CÉSAR LÓPEZ-CAMARILLO
    Oncology Reports.2016; 35(6): 3696.     CrossRef
  • Autophagy inhibition augments resveratrol-induced apoptosis in Ishikawa endometrial cancer cells
    Tomohiko Fukuda, Katsutoshi Oda, Osamu Wada-Hiraike, Kenbun Sone, Kanako Inaba, Yuji Ikeda, Chinami Makii, Aki Miyasaka, Tomoko Kashiyama, Michihiro Tanikawa, Takahide Arimoto, Tetsu Yano, Kei Kawana, Yutaka Osuga, Tomoyuki Fujii
    Oncology Letters.2016; 12(4): 2560.     CrossRef
  • Apoptotic Effect of Pinosylvin at a High Concentration Regulated by c-Jun N-Terminal Kinase in Bovine Aortic Endothelial Cells
    Jina Song, Jinsun Park, Eunsil Jeong, A-Young So, Jaeho Pyee, Heonyong Park
    Journal of Life Science.2015; 25(4): 416.     CrossRef
  • Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis
    Jiening Dun, Xueyan Chen, Haixia Gao, Yan Zhang, Huajun Zhang, Yongjian Zhang
    Experimental Biology and Medicine.2015; 240(12): 1672.     CrossRef
  • Pinosylvin at a high concentration induces AMPK-mediated autophagy for preventing necrosis in bovine aortic endothelial cells
    Jinsun Park, Jaeho Pyee, Heonyong Park
    Canadian Journal of Physiology and Pharmacology.2014; 92(12): 993.     CrossRef
  • Resveratrol promotes endothelial cell wound healing under laminar shear stress through an estrogen receptor-α-dependent pathway
    Arif Yurdagul, James J. Kleinedler, Marshall C. McInnis, Alok R. Khandelwal, Allyson L. Spence, A. Wayne Orr, Tammy R. Dugas
    American Journal of Physiology-Heart and Circulatory Physiology.2014; 306(6): H797.     CrossRef
  • Protective Effects of Resveratrol on TNF-α-Induced Endothelial Cytotoxicity in Baboon Femoral Arterial Endothelial Cells
    Juan Xiao, Jun Song, Vida Hodara, Allen Ford, Xing Li Wang, Qiang Shi, Li Chen, John L. VandeBerg
    Journal of Diabetes Research.2013; 2013: 1.     CrossRef
  • Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines
    Fatemehsadat Amiri, Amir-Hassan Zarnani, Hamid Zand, Fariba Koohdani, Mahmood Jeddi-Tehrani, Mohammadreza Vafa
    European Journal of Pharmacology.2013; 718(1-3): 34.     CrossRef
  • Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
    Vittorio Calabrese, Carolin Cornelius, Albena T. Dinkova-Kostova, Ivo Iavicoli, Rosanna Di Paola, Aleardo Koverech, Salvatore Cuzzocrea, Enrico Rizzarelli, Edward J. Calabrese
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2012; 1822(5): 753.     CrossRef
  • Ameliorative Effects of Resveratrol on Acute Ovarian Toxicity Induced by Total Body Irradiation in Young Adult Rats
    Yavuz Simsek, Simay Gurocak, Yusuf Turkoz, Nusret Akpolat, Onder Celik, Ali Ozer, Ercan Yılmaz, Ugur Turhan, Fatma Ozyalin
    Journal of Pediatric and Adolescent Gynecology.2012; 25(4): 262.     CrossRef
  • Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell Development
    Lindsay Peltz, Jessica Gomez, Maribel Marquez, Frances Alencastro, Negar Atashpanjeh, Tara Quang, Thuy Bach, Yuanxiang Zhao, Antonio Paolo Beltrami
    PLoS ONE.2012; 7(5): e37162.     CrossRef
  • Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells
    Minna Kairisalo, Alessandra Bonomo, Alise Hyrskyluoto, Giuseppa Mudò, Natale Belluardo, Laura Korhonen, Dan Lindholm
    Neuroscience Letters.2011; 488(3): 263.     CrossRef
  • Effect of resveratrol on endothelial cell function: Molecular mechanisms
    Christoph A. Schmitt, Elke H. Heiss, Verena M. Dirsch
    BioFactors.2010; 36(5): 342.     CrossRef
  • Dose-Dependency of Resveratrol in Providing Health Benefits
    Subhendu Mukherjee, Jocelyn I. Dudley, Dipak K. Das
    Dose-Response.2010;[Epub]     CrossRef
  • Resveratrol commonly displays hormesis: Occurrence and biomedical significance
    Edward J Calabrese, Mark P Mattson, Vittorio Calabrese
    Human & Experimental Toxicology.2010; 29(12): 980.     CrossRef
  • Biochemical characterization of the lipid-binding properties of a broccoli cuticular wax-associated protein, WAX9D, and its application
    Sun-Young Ahn, Jong-Min Kim, Jae-Ho Pyee, Heon-Yong Park
    BMB Reports .2009; 42(6): 367.     CrossRef
  • 11,255 View
  • 59 Download
  • 21 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP